Login / Signup

Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats.

Kristýna Štefková-MazochováHynek DandaWim DehaenBronislav JurásekKlára ŠíchováNikola Pinterová-LecaVladimír MazochBarbora Hrčka KrausováBohdan KysilovTereza SmejkalovaLadislav VyklickyMichal KohoutKateřina HájkováDaniel SvozilRachel R HorsleyMartin KucharTomáš Páleníček
Published in: British journal of pharmacology (2021)
DCK showed similar behavioural and addictive profiles and pharmacodynamics to ketamine, with S-DCK being in general more active. It has a slightly slower pharmacokinetic profile than ketamine, which is consistent with its reported longer duration of action. These findings have implications and significance for understanding the risks associated with illicit use of DCK.
Keyphrases
  • pain management
  • human health
  • case control
  • risk assessment
  • climate change